People Power Key to Successful Clinical Trial Operations

Technological bells and whistles are nice, innovative processes crafted at the granular level are terrific, but none of it matters much if you don’t have the right people in place, experts gathered for the 4th Annual ACRP Executive Summit in Seattle affirmed April 30. To succeed, “you need great relationships all down the line,” said […]

Ernest Prentice, PhD, Associate Vice Chancellor for Academic Affairs, University of Nebraska Medical Center

The Slippery Slope of Noncompliance Leading to Research Misconduct

“We have a big challenge when we talk about oversight of research…[and] we need to recognize that investigators are human” and may regrettably behave in ways leading to noncompliance or research misconduct, says Ernest D. Prentice, PhD, associate vice chair for academic affairs with the University of Nebraska Medical Center. Presenting a session on “Breaches […]

State of the Industry

New Regulatory Flexibility Driving Positive Industry Change

An exciting regulatory willingness to consider new ways of clinical trial oversight is the single biggest factor driving innovations in the industry. That’s the assessment of Terri Hinkley, Workforce Innovation Officer for the Association of Clinical Research Professionals (ACRP). “We’re a risk-averse industry,” she told attendees kicking off day two of ACRP’s 2017 Meeting & […]

Gazing into the Future of the Shared Investigator Platform

The future of revolutions in communication between study sites and sponsors is being crafted even now through the Shared Investigator Platform initiative described by project members yesterday in a session at the ACRP 2017 Meeting & Expo in Seattle. As described by Summer Iverson, associate director of global clinical trial execution for Pfizer, and Kelly […]

Jan Peterson, Senior Regulatory Affairs Manager and Project Director, Emmes Corporation

Leverage Data Managers to Strengthen Risk-Based Monitoring Programs

Data managers play a critical, and perhaps under recognized, role in fully realizing the potential of risk-based monitoring (RBM), Jan Peterson, senior regulatory affairs manager and project director at Emmes Corporation, told attendees of the Association of Clinical Research Professionals (ACRP) 2017 Meeting & Expo in Seattle April 29. RBM remains a murky concept in […]